European Pharmaceutical Review
JANUARY 27, 2025
Common upstream challenges and solutions The key barriers to a successful tech transfer process are technical (complexity, equivocality and concreteness) and human (communication, motivation and distance). Having a person in plant for some tech transfers facilitates higher levels of communication.
Blog: Ask a Student Pharmacist
AUGUST 22, 2024
FAQs for sites that provide OT services FAQs for Community Sites with No OT services Capstone Presentations 2023 Expand all + Research Focused Experience Studying the Reliability and Precision of the Intermetacarpal Distance Method in Persons with Thumb Osteoarthritis Research_ Test-Retest Reliability of the GripAble Device Interrater Reliability Measures (..)
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
JANUARY 9, 2025
Automation: Email marketing and CRM tools streamline communication, saving time while maintaining personalization. Technologies like AI, big data, and AR/VR streamline processes, improve targeting, and create more engaging campaigns. Tools like HubSpot and Salesforce are becoming indispensable in pharma marketing arsenals.
ISPE
OCTOBER 1, 2022
Consistent Measurements from Lab-to-Process Improve Production. Consistent Measurements from Lab-to-Process Improve Production. You may unsubscribe from these ISPE communications at any time. Trudy Patterson. Sat, 10/01/2022 - 06:00. Sponsored Content. 1 October 2022. Leave this field blank.
ISPE
OCTOBER 27, 2022
Combining the incremental process improvements previously mentioned results in an optimized facility, with the adjusted block flow shown in Figure 5. You may unsubscribe from these ISPE communications at any time. Cycling through columns can drastically increase synthesis output. Leave this field blank.
ISPE
MARCH 29, 2023
Challenges with the Current Module 2 Structure The US FDA published a white paper in 2018 calling for a revision to Module 2 because, “there can be a disconnect between applicants and regulators regarding the communication of quality data and its impact on the assessment. Currently, it takes time and/or communications (e.g.,
ISPE
MARCH 29, 2023
Challenges with the Current Module 2 Structure The US FDA published a white paper in 2018 calling for a revision to Module 2 because, “there can be a disconnect between applicants and regulators regarding the communication of quality data and its impact on the assessment. Currently, it takes time and/or communications (e.g.,
Expert insights. Personalized for you.
52 
Let's personalize your content